| Authors: |
Guidetti C; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts., Papakostas GI; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts., Stahl S; Department of Psychiatry, VAMC (SD), University of California, San Diego.; Neuroscience Education Institute, Carlsbad, California., Pani L; Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Miami, Miami, Florida.; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena., De Martin S; Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy., Mattarei A; Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy., Comai S; Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.; Department of Psychiatry, McGill University, Montreal, Quebec, Canada., Kröger C; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts., Champasa P; Daje Life Sciences, LLC, Somerville, Massachusetts., Gorodetzky CW; Consultant in Pharmaceutical Medicine, Kansas City, Missouri., Vocci FJ; Friends Research Institute, Baltimore, Maryland., Kosten TR; Baylor College of Medicine, Houston, Texas., Bushnell D; Cytel Inc., Waltham, Massachusetts, USA., Kappler M; Cytel Inc., Waltham, Massachusetts, USA., Folli F; Department of Health Sciences, University of Milan, Milan, Italy., Inturrisi CE; MGGM LLC, Kerhonkson, New York.; Levomecor Inc., Miami Beach, Florida, USA., Pappagallo M; MGGM LLC, Kerhonkson, New York.; Levomecor Inc., Miami Beach, Florida, USA., Manfredi PL; MGGM LLC, Kerhonkson, New York.; Levomecor Inc., Miami Beach, Florida, USA., Fava M; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts. |
